Clinical Trial Update: Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating ICP-488 in adults with moderate to severe plaque psoriasis, assessing efficacy, safety, and pharmacokinetics. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ICP-488

Snippet

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Conditions: Plaque Psoriasis Patients | Phase 3 | Status: RECRUITING